Novonesis A/S (NVZMY)
OTCMKTS
· Delayed Price · Currency is USD
58.10
-0.47 (-0.79%)
Mar 31, 2025, 12:01 PM EST
Novonesis Revenue
In the year 2024, Novonesis had annual revenue of 3.83B EUR with 59.58% growth. Novonesis had revenue of 1.00B in the quarter ending December 31, 2024, a decrease of -78.26%.
Revenue
3.83B EUR
Revenue Growth
+59.58%
P/S Ratio
n/a
Revenue / Employee
362.27K EUR
Employees
10,582
Market Cap
27.30B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.83B | 1.43B | 59.58% |
Dec 31, 2023 | 2.40B | -15.15B | -86.31% |
Dec 31, 2022 | 17.55B | 2.60B | 17.40% |
Dec 31, 2021 | 14.95B | 939.00M | 6.70% |
Dec 31, 2020 | 14.01B | -362.00M | -2.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Monarch Cement Company | 268.05M |
Venator Materials | 1.56B |
Rubber Leaf | 6.93M |
Cardinal Ethanol, LLC | 350.34M |
Verde Resources | 216.80K |
Nanophase Technologies | 52.35M |
Webco Industries | 575.71M |
Novonesis News
- 4 weeks ago - Novonesis A/S (NVZMF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Novonesis: Still Too Expensive - Seeking Alpha
- 2 months ago - Exciting prospects in bioenergy and functional foods, Novonesis CEO says - CNBC
- 4 months ago - Top 3 global stocks poised for 40% gains by 2025 - Invezz
- 5 months ago - Novonesis A/S (NVZMF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Novonesis: Underperformance In Price, But Now I'm Buying (Rating Upgrade) - Seeking Alpha
- 7 months ago - Novozymes A/S (NVZMF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Novozymes A/S reports 1H results - Seeking Alpha